Essential role of Gli proteins in glioblastoma multiforme

Current Protein and Peptide Science

Volumn 14, Issue 2, 2013, Pages 133-140

  Santoni, Matteo ^a   Burattini, Luciano ^a   Nabissi, Massimo ^b   Morelli, Maria Beatrice ^b   Berardi, Rossana ^a   Santoni, Giorgio ^b   Cascinu, Stefano ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Gli proteins; Glioblastoma; Glioma stem cells; Hedgehog signaling pathway; Temozolomide

Indexed keywords

BMS 833923; BUPARLISIB; CAPECITABINE; CARBOPLATIN; CHEMOKINE RECEPTOR CXCR4; CISPLATIN; CYCLIN D2; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HEPATOCYTE NUCLEAR FACTOR 3BETA; IRINOTECAN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; OXALIPLATIN; SARIDEGIB; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 6; SONIDEGIB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISMODEGIB;

APOPTOSIS; BASAL CELL CARCINOMA; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA REPAIR; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; LUNG SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; NONHUMAN; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOBLASTOMA; HEDGEHOG PROTEINS; HUMANS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ERINACEIDAE;

EID: 84878565258     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203711314020005     Document Type: Review

References (81)

1. Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R.C.; Ludwin, S.K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J.G.; Eisenhauer, E.; Mirimanoff, R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 2005, 352(10), 987-996.
2. Kinzler, K.W.; Bigner, S.H.; Bigner, D.D.; Trent, J.M.; Law, M.L.; O'Brien, S.J.; Wong, A.J.; Vogelstein, B. Identification of an amplified highly expressed gene in human glioma. Science, 1987, 236(4797), 70-73.
3. Dominguez, M.; Brunner, M.; Hafen, E.; Basler, K. Sending and receiving the hedgehog signal: control by the Drosophila Gli protein Cubitus interruptus. Science, 1996, 272(5268), 1621-1625.
4. Wechsler-Reya, R.J.; Scott, M.P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron, 1999, 22(1), 103-114.
5. Alberta, J.A.; Park, S.K.; Mora, J.; Yuk, D.; Pawlitzky, I.; Iannarelli, P.; Vartanian, T.; Stiles, C.D.; Rowitch, D.H. Sonic Hedgehog is required during an early phase of oligodendrocyte development in mammalian brain. Mol. Cell. Neurosci., 2001, 18(4), 434-441.
6. Rowitch, D.H.; S-Jacques, B.; Lee, S.M.; Flax, J.D.; Snyder, E.Y.; McMahon, A.P. Sonic Hedgehog regulates proliferation and inhibits differentiation of CNS precursor cells. J. Neurosci., 1999, 19(20), 8954-8965.
7. Machold, R.; Hayashi, S.; Rutlin, M.; Muzumdar, M.D.; Nery, S.; Corbin, J.G.; Gritli-Linde, A.; Dellovade, T.; Porter, J.A.; Rubin, L.L.; Dudek, H.; McMahon, A.P.; Fishell, G. Sonic Hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron, 2003, 39(6), 937-950.
8. Nery, S.; Wichterle, H.; Fishell, G. Sonic Hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. Development, 2001, 128(4), 527-540.
9. Tekki-Kessaris N.; Woodruff R.; Hall A.C.; Gaffield, W.; Kimura, S.; Stiles, C.D.; Rowitch, D.H.; Richardson, W.D. Hedgehogdependent oligodendrocyte lineage specification in the telencephalon. Development, 2001, 128(13), 2545-2554.
10. Dahmane, N.; Sanchez, P.; Gitton, Y.; Palma, V.; Sun, T.; Beyna, M.; Weiner, H.; Ruiz i Altaba, A. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development, 2001, 128(24), 5201-5212.
11. Echelard, Y.; Epstein, D.J.; St-Jacques, B.; Shen, L.; Mohler, J.; McMahon, J.A.; McMahon, A.P. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell, 1993, 75(7), 1417-1430.
12. Roelink, H.; Augsburger, A.; Heemskerk, J.; Korzh, V.; Norlin, S.; Ruiz i Altaba, A.; Tanabe, Y.; Placzek, M.; Edlund, T.; Jessell, T.M.; Dodd, J. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell, 1994, 76(4), 761-775.
13. Clement, V.; Sanchez, P.; de Tribolet, N.; Radovanovic, I.; Ruiz i Altaba, A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr.Biol., 2007, 17(2), 165-172.
14. Kasper, M.; Regl, G.; Frischauf, A.M.; Aberger, F. GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur. J. Cancer, 2006, 42(4), 437-445.
15. Shahi, M.H.; Lorente, A.; Castresana, J.S. Hedgehog signalling in medulloblastoma, glioblastoma and neuroblastoma. Oncol. Rep., 2008, 19(3), 681-688.
16. Kinzler, K.W.; Vogelstein, B. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol. Cell. Biol., 1990, 10(2), 634-642.
17. Kinzler, K.W.; Ruppert, J.M.; Bigner, S.H.; Vogelstein, B. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature, 1988, 332(6162), 371-374.
18. Wang, B.; Fallon, J.F.; Beachy, P.A. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell, 2000, 100(4), 423-434.
19. Lee, J.J.; von Kessler, D.P.; Parks, S.; Beachy, P.A. Secretion and localized transcription suggest a role in positional signaling for products of the segmentation gene hedgehog. Cell, 1992, 71(1), 33-50.
20. Ma, C.; Zhou, Y.; Beachy, P.A.; Moses, K. The segment polarity gene hedgehog is required for progression of the morphogenetic furrow in the developing Drosophila eye. Cell, 1993, 75(5), 927-938.
21. Orenic, T.V.; Slusarski, D.C.; Kroll, K.L.; Holmgren, R.A. Cloning and characterization of the segment polarity gene cubitus interruptus Dominant of Drosophila. Genes Dev., 1990, 4(6), 1053-1067.
22. Becher, O.J.; Hambardzumyan, D.; Fomchenko, E.I.; Momota, H.; Mainwaring, L.; Bleau, A.M.; Katz, A.M.; Edgar, M.; Kenney, A.M.; Cordon-Cardo, C.; Blasberg, R.G.; Holland, E.C. Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor -Induced Gliomas. Cancer Res., 2008, 68(7), 2241-2249.
23. Salgaller, M.; Pearl, D.; Stephens, R. In situ hybridization with single-stranded RNA probes to demonstrate binfrequently elevated gli mRNA and no increased ras mRNA levels in meningiomas and astrocytomas. Cancer Lett., 1991, 57(3), 243-253.
24. Xiao, H.; Goldthwait, D.A.; Mapstone, T. A search for gli expression in tumors of the central nervous system. Pediatr. Neurosurg., 1994, 20(3), 178-182.
25. Katayam, M.; Yoshida, K.; Ishimori, H.; Katayama, M.; Kawase, T.; Motoyama, J.; Kamiguchi, H. Patched and smoothened mRNA expression in human astrocytic tumors inversely correlates with histological malignancy. J. Neurooncol., 2002, 59(2), 107-115.
26. Gerardo Valadez, J.; Grover, V.K.; Carter, M.D.; Calcutt, M.W.; Abiria, S.A.; Lundberg, C.J.; Williams, T.V.; Cooper, M.K. Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation. Cancer Lett. 2013, 328(2):297-306.
27. Marigo, V.; Johnson, R.L.; Vortkamp, A.; Tabin, C.J. Sonic hedgehog differentially regulates expression of GLI and GLI3 during limb development. Dev. Biol., 1996, 180(1), 273-283.
28. Lee, J.; Platt, K.A.; Censullo, P.; Ruiz i Altaba, A. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development, 1997, 124(), 2537-2552.
29. Hynes, M.; Stone, D.M.; Dowd, M.; Pitts-Meek, S.; Goddard, A.; Gurney, A.; Rosenthal, A. Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1. Neuron, 1997, 19(1), 15-26.
30. Huntzicker, E.G.; Estay, I.S.; Zhen, H.; Lokteva, L.A.; Jackson, P.K.; Oro, A.E. Dual degradation signals control Gli protein stability and tumor formation. Genes Dev., 2006, 20(3), 276-281.
31. Dunaeva, M.; Michelson, P.; Kogerman, P.; Toftgard, R. Characterization of the physical interaction of Gli proteins with SUFU proteins. J. Biol. Chem., 2003, 278(7), 5116-5122.
32. Yoon, J.W.; Liu, C.Z.; Yang, J.T.; Swart, R.; Iannaccone, P.; Walterhouse, D. GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain. J. Biol. Chem., 1998, 273(6), 3496-3501.
33. Bigner, S.H.; Wong, A.J.; Mark, J.; Muhlbaier, L.H.; Kinzler, K.W.; Vogelstein, B.; Bigner, D.D. Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet. Cytogenet., 1987, 29(1), 165-170.
34. Wong, A.J.; Bigner, S.H.; Bigner, D.D.; Kinzler, K.W.; Hamilton, S.R.; Vogelstein, B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. U.S.A., 1987, 84(19), 6899-6903.
35. Forus, A.; Florenes, V.A.; Maelandsmo, G.M.; Meltzer, P.S.; Fodstad, O.; Myklebost, O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ., 1993, 4(12), 1065-1070.
36. Sasaki, H.; Hui, C.; Nakafuku, M.; Kondoh, H. A binding site for bGli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development, 1997, 124(7), 1313-1322.
37. Teh, M.T.; Wong, S.T.; Neill, G.W.; Ghali, L.R.; Philpott, M. P.; Quinn, A.G. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res., 2002, 62(16), 4773-4780.
38. Laner-Plamberger, S.; Kaser, A.; Paulischta, M.; Hauser-Kronberger, C.; Eichberger, T.; Frischauf, A. M. Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes. Oncogene, 2009, 28(13), 1639-1651.
39. Liu, M.; Dai, B.; Kang, S.H.; Ban, K.; Huang, F.J.; Lang, F.F.; Aldape, K.D.; Xie, T.X.; Pelloski, C.E.; Xie, K.; Sawaya, R.; Huang, S. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res., 2006, 66(7), 3593-3602.
40. Dai, B.; Pieper, R.O.; Li, D.; Wei, P.; Liu, M.; Woo, S.Y.; Aldape, K.D.; Sawaya, R.; Xie, K.; Huang, S. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res., 2010, 70(7), 2951-2961.
41. Bowman, A.; Nusse, R. Location, location, location: FoxM1 mediates β-catenin nuclear translocation and promotes glioma tumorigenesis. Cancer Cell, 2011, 20(4), 415-416.
42. Liu, X.; Wang, L.; Zhao, S.; Ji, X.; Luo, Y.; Ling, F. β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells. Med. Oncol., 2011, 28(2), 608-614.
43. Pourquier, P.; Montaudon, D.; Huet, S.; Larrue, A.; Clary, A.; Robert, J. Doxorubicin-induced alterations of c-myc and cjun gene expression in rat glioblastoma cells: role of c-jun in drug resistance and cell death. Biochem. Pharmacol., 1998, 55(12), 1963-1971.
44. Yoon, J.W.; Kita, Y.; Frank, D.J.; Majewski, R.R.; Konicek, B.A.; Nobrega, M.A.; Jacob, H.; Walterhouse, D.; Iannaccone, P. Gene Expression Profiling Leads to Identification of GLI1-binding Elements in Target Genes and a Role for Multiple Downstream Pathways in GLI1-induced Cell Transformation. J. Biol. Chem., 2002, 277(7), 5548-5555.
45. Bach, L.A. IGFBP-6 five years on; not so 'forgotten'? Growth Horm. IGF Res., 2005, 15(3), 185-192.
46. Yoon, J.W.; Gilbertson, R.; Iannaccone, S.; Iannaccone, P.; Walterhouse, D. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes. Int. J. Cancer, 2009, 124(1), 109-119.
47. Louro, I.D.; Bailey, E.C.; Li, X.; South, L.S.; McKie-Bell, P.R.; Yoder, B.K.; Huang, C.C.; Johnson, M.R.; Hill, A.E.; Johnson, R.L.; Ruppert, J.M. Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res., 2002, 62(20), 5867-5873.
48. Li, X.; Deng, W.; Nail, C.D.; Bailey, S.K.; Kraus, M.H.; Ruppert, J.M.; Lobo-Ruppert, S.M. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene, 2006, 25(4), 609-621.
49. Han, S.P.; Kim, J.H.; Han, M.E.; Sim, H.E.; Kim, K.S.; Yoon, S.; Baek, S.Y.; Kim, B.S.; Oh, S.O. SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol. Neurobiol., 2011, 31(3), 489-496.
50. Riobo, N.A.; Manning, D.R. Pathways of signal transduction employed by vertebrate Hedgehogs. Biochem. J., 2007, 403(3), 369-379.
51. Pan, Y.; Bai, C.B.; Joyner, A.L.; Wang, B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol. Cell Biol., 2006; 26(9), 3365-3377.
52. Bai, C.B.; Stephen, D.; Joyner, A.L. All mouse ventral spinal cord patterning by Hedgehog is Gli dependent and involves an activator function of Gli3. Dev. Cell, 2004, 6(1), 103-115.
53. Wang, Y.; McMahon, AP.; Allen, B.L. Shifting paradigms in Hedgehog signaling. Curr. Opin. Cell Biol., 2007, 19(2), 159-165.
54. Mo, R.; Freer, A.M.; Zinyk, D.L.; Crackkower, M.A.; Michaud, J.; Heng, H.H.-Q.; Chik, K.W.; Shi, X.-M.; Tsui, L.-C.; Cheng, S.H.; Joyner, A.L.; Hui, C.-C. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development, 1997, 124(1), 113-123.
55. Dai, P.; Akimaru, H.; Tanaka, Y.; Maekawa, T.; Nakafuku, M.; Ishii, S. Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3. J. Biol. Chem., 1999, 274(12), 8143-8152.
56. Hatayama, M.; Aruga, J. Gli protein nuclear localization signal. Vitam. Horm. 2012, 88:73-89.
57. Raffel, C.; Jenkins, R.B.; Frederick, L.; Hebrink, D.; Alderete, B.; Fults, D.W.; James, C.D. Sporadic medulloblastomas contain PTCH mutations. Cancer Res., 1997, 57(5), 842-845.
58. Bailey, E.C.; Milenkovic, L.; Scott, M.P.; Collawn, J.F.; Johnson, R.L. Several PATCHED1 missense mutations display activity in patched1-deficient fibroblasts. J. Biol. Chem., 2002, 277(37), 33632-33640.
59. Lindstrom, E.; Shimokawa, T.; Toftgard, R.; Zaphiropoulos, P.G. PTCH mutations: distribution and analyses. Hum. Mutat., 2006, 27(3), 215-219.
60. Reifenberger, J.; Wolter, M.; Weber, R.G.; Megahed, M.; Ruzicka, T.; Lichter, P.; Reifenberger, G. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res., 1998, 58(9), 1798-1803.
61. Xie, J.; Murone, M.; Luoh, S.M.; Ryan, A.; Gu, Q.; Zhang, C.; Bonifas, J.M.; Lam, C.W.; Hynes, M.; Goddard, A.; Rosenthal, A.; Epstein, E.H.; Jr. de Sauvage F.J. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature, 1998, 391(6662), 90-92.
62. Yauch, R.L.; Dijkgraaf, G.J.; Alicke, B.; Januario, T.; Ahn, C.P.; Holcomb, T.; Pujara, K.; Stinson, J.; Callahan, C.A.; Tang, T.; Bazan, J.F.; Kan, Z.; Seshagiri, S.; Hann, C.L.; Gould, S. E.; Low, J.A.; Rudin, C.M.; de Sauvage, F.J. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science, 2009, 326(5952), 572-574.
63. Roessler, E.; Du, Y.Z.; Mullor, J.L.; Casas, E.; Allen, W.P.; Gillessen-Kaesbach, G.; Roeder, E.R.; Ming, J.E.; Ruiz i Altaba, A.; Muenke, M. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephalylike features. Proc. Natl. Acad. Sci. U.S.A., 2003, 100(23), 13424-13429.
64. Kang, S.; Graham, J.M. Jr.; Olney, A.H.; Biesecker, L.G. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet., 1997, 15(3), 266-268.
65. Radhakrishna, U.; Wild, A.; Grzeschik, K.H.; Antonarakis, S.E. Mutation in GLI3 in postaxial polydactyly type A. Nat. Genet., 1997, 17(3), 269-271.
66. Shimokawa, T.; Tostar, U.; Lauth, M.; Palaniswamy, R.; Kasper, M.; Toftgard, R.; Zaphiropoulos, P.G. Novel human gliomaassociated oncogene 1 (GLI1) splice variants reveal distinct mechanisms in the terminal transduction of the hedgehog signal. J. Biol. Chem., 2008, 283(21), 14345-14354.
67. Lo, H.W.; Zhu, H.; Cao, X.; Aldrich, A.; Ali-Osman, F. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res., 2009, 69(17), 6790-6798.
68. Aigner S.; Sthoeger Z.M.; Fogel M.; Weber E.; Zarn J.; Ruppert M.; Zeller, Y.; Vestweber, D.; Stahel, R.; Sammar, M.; Altevogt, P. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood, 1997, 89(9), 3385-3395.
69. Senner, V.; Sturm, A.; Baur, I.; Schrell, U.H.; Distel, L.; Paulus, W. CD24 promotes invasion of glioma cells in vivo. J. Neuropathol. Exp. Neurol., 1999, 58(8), 795-802.
70. Deng, J.; Gao, G.; Wang, L.; Wang, T.; Yu, J.; Zhao, Z. CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas. J. Biomed. Biotechnol., 2012, 2012, 5171-5172.
71. Uchida, N.; Buck, D.W.; He, D.; Reitsma, M.J.; Masek, M.; Phan, T.V.; Tsukamoto, A.S.; Gage, F.H.; Weissman, I.L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA. 2000, 97(26):14720-14725.
72. Hsieh, A.; Ellsworth, R.; Hsieh, D. Hedgehog/GLI1 Regulates IGF Dependent Malignant Behaviors in Glioma Stem Cells. J. Cell. Physiol., 2011, 226(4), 1118-1127.
73. Parathath S.R.; Mainwaring, L.A.; Fernandez, L.A.; Campbell, D.O.; Kenney, A.M. Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors. Development, 2008, 135(19), 3291-3300.
74. Bao, S.; Wu, Q.; Sathornsumetee, S.; Hao, Y.; Li, Z.; Hjelmeland, A.B.; Shi, Q.; McLendon, R.E.; Bigner, D.D.; Rich, J.N. Stem celllike glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res., 2006, 66(16), 7843-7848.
75. Ricci-Vitiani, L.; Pallini, R.; Biffoni, M.; Todaro, M.; Invernici, G.; Cenci, T.; Maira, G.; Parati, E.A.; Stassi, G.; Larocca, L.M.; De Maria, R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature, 2010, 468(7325), 824-828.
76. Woods, S.A.; McGlade, C.J.; Guha, A. Phosphatidylinositol 30-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells. Neuro-Oncol., 2002, 4(4), 242-252.
77. Fareh, M.; Turchi, L.; Virolle, V.; Debruyne, D.; Almairac, F.; dela-Forest Divonne, S.; Paquis, P.; Preynat-Seauve, O.; Krause, K.H.; Chneiweiss, H.; Virolle, T. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of gliomainitiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ., 2012, 19(2), 232-244.
78. Eramo, A.; Ricci-Vitiani, L.; Zeuner, A.; Pallini, R.; Lotti, F.; Sette, G.; Pilozzi, E.; Larocca, L.M.; Peschle C.; De Maria, R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ., 2006, 13(7):1238-1241.
79. Liu, G.; Yuan, X.; Zeng, Z.; Tunici, P.; Ng, H.; Abdulkadir, I.R.; Lu, L.; Irvin, D.; Black, K.L.; Yu, J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer, 2006, 5, 67.
80. Bao, S.; Wu, Q.; McLendon, R.E.; Hao, Y.; Shi, Q.; Hjelmeland, A.B.; Dewhirst, M.W.; Bigner, D.D.; Rich, J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444(7120), 756-760.
81. Ferruzzi, P.; Mennillo, F.; De Rosa, A.; Giordano, C.; Rossi, M.; Benedetti, G.; Magrini, R.; Pericot Mohr, G.I.; Miragliotta, V.; Magnoni, L.; Mori, E.; Thomas, R.; Tunici, P.; Bakker, A. In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines. Int. J. Cancer. 2012, 131(2):E33-44.